{"id":"W1971705000","doi":"10.1016/j.critrevonc.2011.06.001","title":"Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: A critical review","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Temsirolimus; Medicine; Tolerability; Everolimus; Oncology; Bevacizumab; Renal cell carcinoma; Clinical trial; Internal medicine; Combination therapy; Targeted therapy; Discovery and development of mTOR inhibitors; Intensive care medicine; Cancer; Adverse effect; Chemotherapy; PI3K/AKT/mTOR pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00134801,0.0008788719,0.002945763,0.001212754,0.0002744144,0.0009315667,0.001363023,0.001014175,0.002501832],"category_scores_gemma":[0.001948035,0.0002867226,0.001190536,0.001321937,0.0004717399,0.0009665189,0.0004614787,0.001839084,0.0006013213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000676544,"about_ca_system_score_gemma":0.001342701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001066,"about_ca_topic_score_gemma":0.00269069,"domain_scores_codex":[0.9996836,0.00009380621,0.00006395533,0.00005318066,0.00008133316,0.00002418168],"domain_scores_gemma":[0.9988812,0.0007805314,0.0001147435,0.00001658378,0.0001731499,0.000033773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003663446,0.0001311071,0.0002869266,0.03854036,0.0006804897,0.000245069,0.00004725954,0.0004358341,0.0007928464,0.001642096,0.03385964,0.9229722],"study_design_scores_gemma":[0.0005040213,0.001079099,0.002497599,0.03969191,0.004554491,0.00316309,0.0001812759,0.0004246106,0.001156826,0.00443315,0.9422274,0.00008654662],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007771158,0.9992546,0.00005533775,0.0002560115,0.0001536944,0.000005188037,0.000007946857,0.000001757681,0.0001875706],"genre_scores_gemma":[0.0007866425,0.9982938,0.0001952649,0.0003712853,0.0002364026,0.00001048535,0.00001645957,9.02741e-7,0.00008876255],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002945763,"threshold_uncertainty_score":0.008369505,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2091943021318495,"score_gpt":0.4524947061415655,"score_spread":0.243300404009716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}